NOVAHISTEX DH
SANOFI-AVENTIS CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is NOVAHISTEX DH discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that NOVAHISTEX DH 20MG 5MG has been permanently discontinued (last updated August 4, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is NOVAHISTEX DH not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02049481
Strength
20MG 5MG
Dosage Form
SYRUP
Route
ORAL
Active Ingredient
PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE
Tier
Unrated
Last Updated
2020-08-04
Reason for Shortage
Business reasons
Past Reports for This Drug
NOVAHISTEX DH has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from SANOFI-AVENTIS CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
20MCG · DIN 02464284
10MCG · DIN 02464276
DIN 02464349
100UNIT · DIN 02469901
100UNIT · DIN 02469898
100UNIT · DIN 02469871
0.58MG · DIN 02254506
500UNIT · DIN 02422913
2000UNIT · DIN 02422948
3000UNIT · DIN 02422956
1000UNIT · DIN 02422921
4000UNIT · DIN 02448157